French drug company Sanofi-Aventis (SNY) Tuesday said it has obtained antitrust clearance in connection with its $93.50 per share tender offer for Chattem, Inc (CHTT). MAIN FACTS:

MAIN FACTS:

- The waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976 has expired, which satisfies one of the conditions of the tender offer.

- The tender offer remains subject to the other conditions described in the Offer to Purchase filed January 11, 2010

- The tender offer is scheduled to expire at 1200 midnight, New York City time, on February 8, unless the tender offer is extended.

- By Paris Bureau, Dow Jones Newswires; +331-4017-1740; djnews.paris@dowjones.com
Chattem, Inc. (MM) (NASDAQ:CHTT)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Chattem, Inc. (MM).
Chattem, Inc. (MM) (NASDAQ:CHTT)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Chattem, Inc. (MM).